Jeremy Grushcow retweeted
The #LGBTQ community deserves an explaination of how this paper made it through your review process. @ELSneuroscience @ElsevierConnect @michielams
cc @500QueerSci @OUTbioBoston
Jeremy Grushcow retweeted
I've been thinking a lot about how the economics of genetic testing work for different parts of the healthcare ecosystem. In the end, as do so many things, it comes down to patients taking the reins and demanding more. More on that here: medium.com/speroventures/you…
Jeremy Grushcow retweeted
Great paper 👇👇👇 – at Manhattan, NY
CV disparities among traditionally underrepresented groups in @AllofUsResearch.
The diversity of a dataset of this size is unprecedented- 50% non-White, 10% with disability, 14% LGBTQIA, 10% < high school education, 35% <$35K household income!
ahajournals.org/doi/full/10.… @JAHA_AHA
Jeremy Grushcow retweeted
New publication from our Precision Population Health initiative with @Genomes2People!
How can we study multi-cancer molecular screening, given the high costs and uncertain benefits of conducting randomized trials at the necessary scale?
[a thread]🧵
nature.com/articles/s41591-0…
Jeremy Grushcow retweeted
I wrote this article for my own catharsis. I never expected it to be peer reviewed. When @NEJM accepted it, I experienced my first panic attack. 1/
@WomenInMedicine @WomeninOnc @AMWADoctors @womeninmedchat @WomeninAcademi1
Jeremy Grushcow retweeted
I've been thinking a lot about women's health. Some preliminary insights here. tldr: women aren't small men, women's health is more than reproductive health, and our knowledge gaps are wide. It's time to start closing them. medium.com/speroventures/the…
Jeremy Grushcow retweeted
We have an open search for multiple faculty positions at the Department of Medicine at the University of Chicago. This particular search is for PhD scientists, not MDs. Please RT.
academicjobs.uchicago.edu/po…
Jeremy Grushcow retweeted
OncotypeDX Breast may not work as well in Black women as compared to non-Hispanic White women. Race/Ethnicity and the 21-Gene Recurrence Score and Breast Cancer–Specific Mortality Among US Women ja.ma/2LSUdyg via @JAMAOnc part of @JAMANetwork #BCSM
Jeremy Grushcow retweeted
Cyclica is building the #biotech pipeline of the future, and we're looking for a CFO to be a part of our unique growth strategy. Recognized by the @globeandmail , our CEO, @NaheedKurji, shares how Cyclica continues to grow in the face of adversity. theglobeandmail.com/business…
Jeremy Grushcow retweeted
Are you interested in having an impact on the discovery of new medicines? We are looking for a manager to join our growing Strategic Partnerships team and support our ongoing #collaboration efforts. Visit our careers page to learn more! #drugdiscovery cyclicarx.com/strategic-part…
Jeremy Grushcow retweeted
Behind the scenes of a founder's fundraising experience from the Co-founder and CEO of @Cyclica, @NaheedKurji.
healthtransformer.co/investi…
Jeremy Grushcow retweeted
We've announced the hiring of Dr. Rami Batal in the new role of Senior VP, Commercial Strategy. The creation of this position represents a further step in our partnering efforts for its lead drug, ATB-346, and for our overall drug platform businesswire.com/news/home/2… $ATE.V $ATBPF
Jeremy Grushcow retweeted
Si proud to be part of the genetic counselling community!
Genetic counsellors make a difference in patients' lives everyday. For our own @CoronFanny, that means helping others better understand the link between their genetics and health. #IAmAGeneticCounsellor
Jeremy Grushcow retweeted
Want to learn about BRCA1/2 prevalence and impact in diverse populations? Check out this latest (super cool!!) work by @NouraAbulHusn @ssuckiel #EmilySoper @jodgis @GillianBelbin @deanbobo and many others @SinaiGenHealth @IcahnMountSinai
Exome Sequencing Reveals a High Prevalence of BRCA1 and BRCA2 Founder Variants in a Diverse Population-Based Biobank biorxiv.org/cgi/content/shor… #bioRxiv
Jeremy Grushcow retweeted
Interested in social and behavioral science at the intersection of empathy, technology, and consumer-driven health innovations? Come do a postdoc with me and a terrific group of colleagues at UCSD bit.ly/2kRAOQR
RT appreciated! #Genomics #digitalhealth #ELSI
Jeremy Grushcow retweeted
Such a fun night! Congratulations to the organizers. – at St. John's, Newfoundland and Labrador
Proud to be a sponsor for the @HeartStrokeNL Red Dress event tonight - great fashion AND a great cause!
Jeremy Grushcow retweeted
Our new lab in @broadinstitute @StanleyCenter is hiring! Come join our patient-driven mission to develop drugs for prion disease in our lifetime. Seeking a postdoc g.co/kgs/JLT7RB and research associate g.co/kgs/9oG9qH — help us prevent neurodegeneration!
Jeremy Grushcow retweeted
Antisense oligonucleotides that lower PrP are effective against prion disease in mice: insight.jci.org/articles/vie…
Blog post our new study, what we have learned so far, and the road ahead: prionalliance.org/2019/08/22…
Jeremy Grushcow retweeted
Extreme Polygenicity of Complex Traits Is Explained by Negative Selection cell.com/ajhg/fulltext/S0002…
Jeremy Grushcow retweeted
This is such an important topic - and a really interesting approach. We will definitely be exploring.
An idea on a reference pan-genome model: lh3.github.io/2019/07/08/on-…. This blog post also puts minigraph and gfatools in a broader context. The idea is fairly crude. Let me know what you think.




























